KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Current Assets (2016 - 2025)

Zimmer Biomet Holdings has reported Current Assets over the past 17 years, most recently at $5.1 billion for Q4 2025.

  • Quarterly results put Current Assets at $5.1 billion for Q4 2025, up 9.6% from a year ago — trailing twelve months through Dec 2025 was $5.1 billion (up 9.6% YoY), and the annual figure for FY2025 was $5.1 billion, up 9.6%.
  • Current Assets for Q4 2025 was $5.1 billion at Zimmer Biomet Holdings, down from $5.8 billion in the prior quarter.
  • Over the last five years, Current Assets for ZBH hit a ceiling of $5.8 billion in Q3 2025 and a floor of $4.4 billion in Q3 2023.
  • Median Current Assets over the past 5 years was $4.7 billion (2024), compared with a mean of $4.8 billion.
  • Biggest five-year swings in Current Assets: dropped 21.52% in 2021 and later increased 20.7% in 2025.
  • Zimmer Biomet Holdings' Current Assets stood at $4.9 billion in 2021, then fell by 9.37% to $4.4 billion in 2022, then grew by 4.12% to $4.6 billion in 2023, then increased by 1.35% to $4.7 billion in 2024, then increased by 9.6% to $5.1 billion in 2025.
  • The last three reported values for Current Assets were $5.1 billion (Q4 2025), $5.8 billion (Q3 2025), and $5.1 billion (Q2 2025) per Business Quant data.